Nanoparticles: the future for platinum drugs or a research red herring?
Field | Value | Language |
dc.contributor.author | Wheate, Nial | |
dc.date.accessioned | 2014-09-22 | |
dc.date.available | 2014-09-22 | |
dc.date.issued | 2012-01-01 | |
dc.identifier.citation | Nanomedicine, 2012, 7, 1285-1287 | en_AU |
dc.identifier.issn | 1743-5889 | |
dc.identifier.uri | http://hdl.handle.net/2123/11965 | |
dc.language.iso | en_AU | en_AU |
dc.publisher | Future Science Group | en_AU |
dc.subject | cancer | en_AU |
dc.subject | carbon nanotubes | en_AU |
dc.subject | cisplatin | en_AU |
dc.subject | dendrimer | en_AU |
dc.subject | liposome | en_AU |
dc.subject | nanoparticle | en_AU |
dc.subject | oxaliplatin | en_AU |
dc.subject | passive targeting | en_AU |
dc.subject | polymer | en_AU |
dc.title | Nanoparticles: the future for platinum drugs or a research red herring? | en_AU |
dc.type | Article | en_AU |
dc.subject.asrc | 111504 | en_AU |
dc.subject.asrc | 111205 | en_AU |
dc.type.pubtype | Publisher's version | en_AU |
Associated file/s
Associated collections